产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 原料药 抗感染药物原料 Ciprofloxacin i...

Ciprofloxacin injection

2026-02-27
 元/个
85721-33-1
企业标准
Injection grade

产品详情

Ciprofloxacin injection
其他抗感染类
85721-33-1
企业标准
Injection grade
Ciprofloxacin,Antibacterial Therapy,Intravenous Administration,Broad-Spectrum Antibiotic
中国,北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

PRODUCT NAME:Ciprofloxacin injection
STRENGTH:0.2%W/V
PACKING DETAILS:100ml/bottle
STORAGE:Store in a cool and dry place below 25ºC, protected from light.
SHELF LIFE:24 months
REGISTRATION DOSSIERS ARE AVAILABLE.
CONSIGNMENT MANUFACTURING, BRAND OEM/ODM SERVICE IS AVAILABLE.

Ciprofloxacin Injection exerts its antibacterial effect by inhibiting the bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and transcription. This action leads to bacterial cell death.Ciprofloxacin Injection exerts its antibacterial effect by inhibiting the bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and transcription. This action leads to bacterial cell death.

Dosage and Administration

  • Adults:The usual dosage is 200 to 400 mg administered intravenously every 8 to 12 hours, depending on the severity of the infection.
  • Children:The dosage should be adjusted based on body weight and the type of infection. It is generally recommended to use 5 to 10 mg/kg of body weight per day, divided into two or three doses.Note:The injection should be administered slowly over a period of 60 minutes to avoid rapid infusion-related adverse effects.


Storage

Store Ciprofloxacin Injection at controlled room temperature (15-30°C) and protect from light and moisture. Do not freeze.

上海浦津林州制药有限公司
访问店铺
注册资本
联系人

公司简介

上海浦津林州制药有限公司,始建于1974年,其前身是林州市市属工业企业--安阳市化学制药厂, 2015年9月更名为“上海浦津林州制药有限公司” 公司位于风景秀丽的太行山东麓,举世闻名的人工天河——红旗渠畔,交通便利,通讯发达。公司占地面积5.5万m2,建筑面积1.9万m2,其中仓储面积3000 m2;厂区绿化面积16000 m2,硬化面积8000 m2。现有职工300余人,固定资产总值6418万元,主导产品主要有葡萄糖酸钙、硫酸镁、维生素C、肌苷等35个注射液品种,在市场上深受广大客户青睐,市场前景广阔。公司为了进一步扩大生产规模,提升产品档次,提高市场占有率,先后投资3.6亿余元,进行技术改造,现在拥有12条符合国家GMP标准的小容量注射剂全自动生产线,并于2014年5月通过国家食品药品监督管理局GMP认证;新建车间年设计生产能力12亿支,可实现产值3亿多元,利税5000余万元。 近年来,公司创新意识不断增强,始终把“技术创新,科技兴厂”作为公司发展的宗旨,企业发展空间大、前景广阔,愿各界同仁、有识之士携手并进,共谋美好未来。